1 purchase reported after at least 12 months of silence — most recent on 27 Feb 2023.
Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Adicet Bio, Inc. | 5,243,259 | reported | 12 Feb 2021 | tx 2+524,349 |
| BiomX Inc. | 3,161,489 | reported | 27 Feb 2023 | tx 7+2,152,159 |
| Eledon Pharmaceuticals, Inc. | 73,650 | reported | 02 Dec 2020 | tx 1−103,200 |
| Chemomab Therapeutics Ltd. | 28,817 | reported | 16 Mar 2021 | tx 2+316,987 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 27 Feb 2023 | PURCHASE | BiomX Inc. | 348,000 | 0.25 USD | first after silence |
| 27 Feb 2023 | PURCHASE | BiomX Inc. | 1,789,959 | — | deriv |
| 16 Mar 2021 | GRANT_AWARD | Chemomab Therapeutics Ltd. | 288,170 | 17.35 USD | |
| 16 Mar 2021 | GRANT_AWARD | Chemomab Therapeutics Ltd. | 28,817 | — |
deriv |
| 12 Feb 2021 | GRANT_AWARD | Adicet Bio, Inc. | 104,050 | 13.00 USD |
| 12 Feb 2021 | GRANT_AWARD | Adicet Bio, Inc. | 420,299 | 13.00 USD |
| 02 Dec 2020 | SALE | Eledon Pharmaceuticals, Inc. | 103,200 | 21.60 USD |
| 19 Dec 2019 | PURCHASE | BiomX Inc. | 3,500 | 8.90 USD |
| 18 Dec 2019 | PURCHASE | BiomX Inc. | 500 | 8.93 USD |
| 09 Dec 2019 | PURCHASE | BiomX Inc. | 6,000 | 8.68 USD |
| 06 Dec 2019 | PURCHASE | BiomX Inc. | 800 | 8.00 USD |
| 05 Dec 2019 | PURCHASE | BiomX Inc. | 3,400 | 7.99 USD |